Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 16 | 2022 | 166 | 3.420 |
Why?
|
| Air Ambulances | 6 | 2020 | 19 | 2.710 |
Why?
|
| Trauma Centers | 12 | 2022 | 114 | 1.650 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2022 | 36 | 1.290 |
Why?
|
| Emergency Medical Services | 6 | 2022 | 78 | 1.240 |
Why?
|
| Ambulances | 3 | 2020 | 12 | 1.160 |
Why?
|
| Surgeons | 3 | 2023 | 49 | 1.150 |
Why?
|
| Injury Severity Score | 10 | 2022 | 117 | 1.120 |
Why?
|
| Retrospective Studies | 23 | 2024 | 2454 | 0.920 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2023 | 3 | 0.880 |
Why?
|
| Veterans | 2 | 2022 | 66 | 0.860 |
Why?
|
| Elasticity | 1 | 2023 | 49 | 0.830 |
Why?
|
| Platelet Function Tests | 1 | 2022 | 24 | 0.820 |
Why?
|
| Humans | 48 | 2024 | 27119 | 0.810 |
Why?
|
| Coronary Artery Bypass | 1 | 2022 | 68 | 0.790 |
Why?
|
| Brain Ischemia | 1 | 2023 | 82 | 0.780 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 133 | 0.750 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 68 | 0.740 |
Why?
|
| Afghan Campaign 2001- | 2 | 2022 | 11 | 0.730 |
Why?
|
| Iraq War, 2003-2011 | 2 | 2022 | 11 | 0.730 |
Why?
|
| Headache | 2 | 2022 | 30 | 0.720 |
Why?
|
| Blood Platelets | 1 | 2023 | 203 | 0.720 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 213 | 0.710 |
Why?
|
| Transportation of Patients | 2 | 2019 | 28 | 0.680 |
Why?
|
| Stroke | 1 | 2023 | 241 | 0.670 |
Why?
|
| Registries | 8 | 2019 | 383 | 0.630 |
Why?
|
| Hospital Mortality | 4 | 2020 | 146 | 0.620 |
Why?
|
| Patient Discharge | 4 | 2022 | 97 | 0.610 |
Why?
|
| Rural Health Services | 1 | 2018 | 22 | 0.590 |
Why?
|
| General Surgery | 3 | 2021 | 53 | 0.510 |
Why?
|
| Rural Population | 2 | 2016 | 99 | 0.460 |
Why?
|
| Postoperative Complications | 4 | 2024 | 605 | 0.450 |
Why?
|
| Blood Transfusion | 3 | 2023 | 73 | 0.440 |
Why?
|
| Triage | 4 | 2022 | 32 | 0.440 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 73 | 0.430 |
Why?
|
| Emergency Service, Hospital | 6 | 2024 | 117 | 0.430 |
Why?
|
| Cholelithiasis | 2 | 2024 | 10 | 0.430 |
Why?
|
| Adolescent | 9 | 2021 | 2988 | 0.420 |
Why?
|
| Propensity Score | 2 | 2019 | 54 | 0.420 |
Why?
|
| Thrombelastography | 2 | 2023 | 46 | 0.410 |
Why?
|
| Automobiles | 1 | 2011 | 2 | 0.370 |
Why?
|
| Male | 18 | 2024 | 13022 | 0.370 |
Why?
|
| Female | 19 | 2024 | 14635 | 0.360 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 27 | 0.360 |
Why?
|
| Case-Control Studies | 3 | 2018 | 705 | 0.350 |
Why?
|
| Abbreviated Injury Scale | 1 | 2010 | 4 | 0.350 |
Why?
|
| Adult | 13 | 2024 | 7492 | 0.340 |
Why?
|
| Risk Factors | 8 | 2024 | 2030 | 0.330 |
Why?
|
| Telemedicine | 2 | 2022 | 164 | 0.320 |
Why?
|
| Internship and Residency | 2 | 2021 | 228 | 0.300 |
Why?
|
| Oklahoma | 5 | 2018 | 978 | 0.290 |
Why?
|
| Patient Transfer | 4 | 2022 | 42 | 0.280 |
Why?
|
| Cholecystectomy | 2 | 2024 | 15 | 0.280 |
Why?
|
| Child | 7 | 2021 | 2160 | 0.260 |
Why?
|
| Obesity | 2 | 2023 | 654 | 0.260 |
Why?
|
| Blood Coagulation | 2 | 2023 | 116 | 0.250 |
Why?
|
| Middle Aged | 11 | 2024 | 6900 | 0.250 |
Why?
|
| Bronchoscopy | 2 | 2024 | 34 | 0.250 |
Why?
|
| Glasgow Coma Scale | 2 | 2018 | 18 | 0.240 |
Why?
|
| Thoracic Surgery | 1 | 2024 | 14 | 0.230 |
Why?
|
| Postpartum Hemorrhage | 1 | 2024 | 9 | 0.230 |
Why?
|
| Erythrocyte Transfusion | 1 | 2024 | 15 | 0.230 |
Why?
|
| Ambulatory Care Facilities | 1 | 2024 | 51 | 0.220 |
Why?
|
| Spleen | 2 | 2021 | 109 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 2 | 2024 | 46 | 0.220 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 340 | 0.220 |
Why?
|
| Robotic Surgical Procedures | 1 | 2024 | 43 | 0.220 |
Why?
|
| Antifibrinolytic Agents | 1 | 2023 | 22 | 0.210 |
Why?
|
| Sex Factors | 3 | 2021 | 452 | 0.210 |
Why?
|
| Child, Preschool | 4 | 2020 | 1100 | 0.210 |
Why?
|
| Blood Coagulation Factors | 1 | 2023 | 31 | 0.210 |
Why?
|
| Medicine | 1 | 2023 | 22 | 0.210 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 26 | 0.210 |
Why?
|
| Logistic Models | 2 | 2016 | 398 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 68 | 0.200 |
Why?
|
| Needs Assessment | 2 | 2019 | 53 | 0.200 |
Why?
|
| Metastasectomy | 1 | 2022 | 6 | 0.200 |
Why?
|
| Afghanistan | 1 | 2022 | 3 | 0.200 |
Why?
|
| Iraq | 1 | 2022 | 4 | 0.200 |
Why?
|
| Dizziness | 1 | 2022 | 10 | 0.200 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 104 | 0.200 |
Why?
|
| Platelet Count | 1 | 2023 | 112 | 0.200 |
Why?
|
| Cholecystitis | 1 | 2022 | 3 | 0.200 |
Why?
|
| Tertiary Care Centers | 2 | 2021 | 26 | 0.200 |
Why?
|
| Quality Improvement | 1 | 2023 | 113 | 0.200 |
Why?
|
| Spine | 1 | 2022 | 60 | 0.200 |
Why?
|
| Aged | 9 | 2024 | 5222 | 0.200 |
Why?
|
| Thrombosis | 1 | 2023 | 147 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 87 | 0.190 |
Why?
|
| Consumer Advocacy | 1 | 2021 | 10 | 0.190 |
Why?
|
| Social Justice | 1 | 2021 | 12 | 0.190 |
Why?
|
| Abdominal Injuries | 1 | 2021 | 29 | 0.190 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2021 | 46 | 0.190 |
Why?
|
| Appendiceal Neoplasms | 1 | 2021 | 5 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 217 | 0.190 |
Why?
|
| Hemorrhage | 1 | 2023 | 260 | 0.190 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 171 | 0.180 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2021 | 31 | 0.180 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 10 | 0.180 |
Why?
|
| Vaccination Coverage | 1 | 2020 | 11 | 0.180 |
Why?
|
| Aircraft | 1 | 2020 | 4 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 133 | 0.180 |
Why?
|
| Splenectomy | 1 | 2020 | 43 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2020 | 67 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2020 | 75 | 0.170 |
Why?
|
| Hepatectomy | 1 | 2020 | 26 | 0.170 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 17 | 0.170 |
Why?
|
| United States | 2 | 2023 | 2060 | 0.170 |
Why?
|
| Thoracostomy | 1 | 2019 | 4 | 0.170 |
Why?
|
| Vena Cava Filters | 1 | 2019 | 11 | 0.170 |
Why?
|
| Chest Tubes | 1 | 2019 | 9 | 0.170 |
Why?
|
| Needles | 1 | 2019 | 26 | 0.170 |
Why?
|
| Device Removal | 1 | 2019 | 30 | 0.170 |
Why?
|
| Pneumothorax | 1 | 2019 | 15 | 0.160 |
Why?
|
| Emergency Treatment | 1 | 2019 | 26 | 0.160 |
Why?
|
| Traumatology | 1 | 2019 | 19 | 0.160 |
Why?
|
| Age Factors | 2 | 2018 | 721 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 928 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 164 | 0.150 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 126 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2019 | 293 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 930 | 0.140 |
Why?
|
| Hospitals, Animal | 1 | 2016 | 1 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 299 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 466 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 2626 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2018 | 846 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 404 | 0.120 |
Why?
|
| Prevalence | 1 | 2016 | 478 | 0.120 |
Why?
|
| Infant | 1 | 2018 | 966 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2024 | 595 | 0.110 |
Why?
|
| Electromagnetic Phenomena | 2 | 2024 | 15 | 0.110 |
Why?
|
| Clinical Competence | 3 | 2021 | 216 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2024 | 229 | 0.100 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2011 | 10 | 0.090 |
Why?
|
| Thoracotomy | 1 | 2011 | 16 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2011 | 49 | 0.090 |
Why?
|
| Geography | 1 | 2011 | 47 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2010 | 7 | 0.090 |
Why?
|
| Observer Variation | 1 | 2010 | 43 | 0.090 |
Why?
|
| Wounds, Penetrating | 2 | 2020 | 23 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 1940 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 988 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 422 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2020 | 162 | 0.060 |
Why?
|
| Aminocaproic Acid | 1 | 2023 | 6 | 0.060 |
Why?
|
| Factor Xa | 1 | 2023 | 13 | 0.060 |
Why?
|
| Delivery, Obstetric | 1 | 2024 | 38 | 0.060 |
Why?
|
| Thrombin | 1 | 2024 | 68 | 0.060 |
Why?
|
| Postpartum Period | 1 | 2024 | 64 | 0.060 |
Why?
|
| Fibrinolysin | 1 | 2023 | 15 | 0.050 |
Why?
|
| Animals | 2 | 2016 | 10080 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2023 | 52 | 0.050 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2023 | 8 | 0.050 |
Why?
|
| Prothrombin | 1 | 2023 | 15 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 33 | 0.050 |
Why?
|
| Factor VIII | 1 | 2023 | 19 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 28 | 0.050 |
Why?
|
| Biopsy | 1 | 2024 | 201 | 0.050 |
Why?
|
| Sex | 1 | 2023 | 5 | 0.050 |
Why?
|
| Factor VIIa | 1 | 2023 | 29 | 0.050 |
Why?
|
| Factor Xa Inhibitors | 1 | 2023 | 53 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 11 | 0.050 |
Why?
|
| Aftercare | 1 | 2022 | 32 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 44 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2022 | 116 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2022 | 34 | 0.050 |
Why?
|
| Current Procedural Terminology | 1 | 2021 | 11 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 1570 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 462 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2002 | 95 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 163 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 73 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2021 | 51 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 462 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 104 | 0.050 |
Why?
|
| Meningitis | 1 | 2020 | 11 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 122 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 103 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 189 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 125 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2022 | 216 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 139 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 32 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 763 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2020 | 2283 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 397 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 251 | 0.040 |
Why?
|
| Sepsis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 1149 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 68 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 424 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 271 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 252 | 0.040 |
Why?
|
| Hypotension | 1 | 2019 | 18 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 40 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 278 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 1219 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2020 | 389 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 472 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 234 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 353 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 189 | 0.040 |
Why?
|
| Incidence | 1 | 2019 | 553 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 863 | 0.030 |
Why?
|
| Alberta | 1 | 2011 | 3 | 0.020 |
Why?
|
| Learning Curve | 1 | 2011 | 13 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 215 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 37 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2002 | 8 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2002 | 72 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 182 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 345 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 443 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 182 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2002 | 229 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 667 | 0.010 |
Why?
|